scholarly article | Q13442814 |
P50 | author | Peyman Adibi | Q61892449 |
P2093 | author name string | Hamidreza Roohafza | |
Hamid Afshar | |||
Ammar Hasanzadeh-Keshteli | |||
Ehsan Zare Bidaki | |||
Hamed Daghaghzade | |||
P2860 | cites work | Psychological treatments for the management of irritable bowel syndrome | Q24241516 |
The 12-item General Health Questionnaire (GHQ-12): translation and validation study of the Iranian version | Q24798283 | ||
The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version | Q24802886 | ||
The hospital anxiety and depression scale | Q27860968 | ||
Functional bowel disorders | Q29620328 | ||
The functional gastrointestinal disorders and the Rome III process | Q34567301 | ||
A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? | Q34579351 | ||
Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain | Q34641950 | ||
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis | Q34657632 | ||
AGA technical review on irritable bowel syndrome | Q35010302 | ||
Psychosocial aspects of functional gastrointestinal disorders | Q35176956 | ||
Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome | Q35596065 | ||
Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors | Q36111329 | ||
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meetingROMEII criteria for irritable bowel syndrome | Q36308712 | ||
Rome III: New standard for functional gastrointestinal disorders | Q36609422 | ||
Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review | Q37051409 | ||
Serotonin, inflammation, and IBS: fitting the jigsaw together? | Q37054089 | ||
Functional gastrointestinal disorders as a public health problem | Q37134568 | ||
Serotonin and GI clinical disorders. | Q37237965 | ||
Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers | Q37338026 | ||
Mental health survey of the adult population in Iran. | Q39672739 | ||
A scaled version of the General Health Questionnaire | Q41464625 | ||
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? | Q41967732 | ||
Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria | Q43763654 | ||
Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. | Q44124963 | ||
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome | Q46431252 | ||
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome | Q46885942 | ||
Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community cohort study | Q60618393 | ||
Psychosocial Aspects of the Functional Gastrointestinal Disorders | Q60701387 | ||
Medical costs in community subjects with irritable bowel syndrome | Q71584338 | ||
P921 | main subject | irritable bowel syndrome | Q838966 |
P304 | page(s) | 183 | |
P577 | publication date | 2016-11-28 | |
P1433 | published in | Advanced biomedical research | Q27724488 |
P1476 | title | Anxiety, depression and distress among irritable bowel syndrome and their subtypes: An epidemiological population based study | |
P478 | volume | 5 |
Q91867706 | A Framework for Understanding the Role of Psychological Processes in Disease Development, Maintenance, and Treatment: The 3P-Disease Model |
Q96576534 | Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms |
Q51415182 | Connecting Our Gut Feeling and How Our Gut Feels: The Role of Well-being Attributes in Irritable Bowel Syndrome. |
Q64052966 | Helicobacter pylori Vacuolating Cytotoxin A Causes Anorexia and Anxiety via Hypothalamic Urocortin 1 in Mice |
Q47153705 | Mechanisms of Stress-induced Visceral Pain |
Q48104300 | Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome. |
Q39411374 | The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis |
Q90376906 | The role of the brain-gut-microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders |
Search more.